DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $29.00 by Analysts at Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price decreased by investment analysts at Needham & Company LLC from $34.00 to $29.00 in a report released on Friday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s price target points to a potential upside of 24.41% from the company’s current price.

Other equities analysts also recently issued reports about the company. Evercore ISI lowered their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Stifel Nicolaus lowered their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Barrington Research restated an “outperform” rating and set a $36.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $32.67.

DENTSPLY SIRONA Stock Performance

XRAY opened at $23.31 on Friday. The business has a fifty day simple moving average of $25.22 and a 200 day simple moving average of $26.47. The company has a market capitalization of $4.73 billion, a PE ratio of -27.10, a price-to-earnings-growth ratio of 1.17 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. DENTSPLY SIRONA has a 1 year low of $22.85 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s revenue was down 4.3% compared to the same quarter last year. During the same period last year, the business earned $0.51 EPS. Research analysts expect that DENTSPLY SIRONA will post 1.98 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of XRAY. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of DENTSPLY SIRONA by 44.2% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock worth $4,684,000 after buying an additional 43,230 shares in the last quarter. Scientech Research LLC purchased a new position in DENTSPLY SIRONA during the second quarter worth about $846,000. Seven Eight Capital LP bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $1,409,000. Illinois Municipal Retirement Fund increased its position in shares of DENTSPLY SIRONA by 369.9% in the first quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock worth $4,102,000 after purchasing an additional 97,281 shares during the last quarter. Finally, Intech Investment Management LLC bought a new stake in DENTSPLY SIRONA during the first quarter valued at approximately $1,202,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.